---
category: news
title: "First Four Patients In Bionic Sightâ€™s Optogenetic Gene Therapy Trial Are Able To Detect Light And Motion"
excerpt: "Bionic Sight, LLC announced today that the first four patients that received BS01, an investigational gene therapy for advanced stage Retinitis Pigmentosa, are showing biological activity. The patients,"
publishedDateTime: 2021-03-30T06:00:00Z
originalUrl: "https://www.morningstar.com/news/globe-newswire/8207965/first-four-patients-in-bionic-sights-optogenetic-gene-therapy-trial-are-able-to-detect-light-and-motion"
webUrl: "https://www.morningstar.com/news/globe-newswire/8207965/first-four-patients-in-bionic-sights-optogenetic-gene-therapy-trial-are-able-to-detect-light-and-motion"
type: article
quality: 4
heat: 4
published: false

provider:
  name: Morningstar, Inc.
  domain: morningstar.com

topics:
  - Computer Vision
  - AI
  - AI in Healthcare

secured: "KHJG1RosP31JLeICFzJXWTXRRm0wq+TQ3HPYbND+3fBgPV44fcIhMn38z0ddSlfbYCdKeKDkpNQHJGhB7kisbLxD2nW0HJZgq8kG18n8jLb1y6VLn1HVOwsLusK7q8rx2H+TC0IyhqsgAs3P4QxqdRw9Dduh6lxDvwEnFr4qmUStJux5i7PciO0dUNcOB5H6VDi4igFNB+PGRxCUIh9DtdjhsXaclkgKz30+8IdcZiw/firjDDTVY7ioI7Rzv1A8lSdXkGGxrbP7614nuliNRHSTCONAA+lqxZ2ybsXh7q+MPh75P6cUKv+2MVKGavilOBMLUCKJ+F7rwohXdu5lXkNhLyWcNL4lju5fd9R2350=;WEpB3oGcEcQPMKROmhjohw=="
---

